Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1985 Mar;21(3):454–456. doi: 10.1128/jcm.21.3.454-456.1985

Inability to adequately control antimicrobial agents on AutoMicrobic System Gram-Positive and Gram-Negative Susceptibility Cards.

J A Kellogg
PMCID: PMC271686  PMID: 3980698

Abstract

The Vitek Gram-Positive Susceptibility Card (GPS) and Gram-Negative General Susceptibility Plus Card (GSC Plus) were tested on the AutoMicrobic System (AMS) 50 times each with the recommended control organisms. Only 1 drug (chloramphenicol) of 11 on the GPS and 1 (gentamicin) of 10 on the GSC Plus could be adequately controlled, leaving unsubstantiated the results obtained with patient isolates on the remaining 19 antimicrobial agents.

Full text

PDF
454

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Kellogg J. A. Inability to control selected drugs on commercially obtained microdilution MIC panels. Am J Clin Pathol. 1984 Oct;82(4):455–458. doi: 10.1093/ajcp/82.4.455. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES